Allergan (AGN) Says FDA Approves AGN's Once-Daily Prescription Eye Drop LUMIGAN 0.03% As First-Line Treatment of Elevated Intraocular Pressure
Tweet Send to a Friend
Allergan, Inc. (NYSE: AGN) announced that the United States Food and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
